CompanyDrug

Shanghai Pharmaceuticals Gets NMPA Approval for B013 in Triple-Negative Breast Cancer

CompanyDrug

Scitop Bio-tech’s KEX02 Live Bacteria Therapy Gets FDA IND Approval for NSCLC

CompanyDeals

Sanyou Biopharmaceuticals and KangaBio Ink Licensing Deal for Antibody Drug Candidate

Company

InnoCare Pharma’s 2022 Interim Report Shows Strong Revenue Growth Driven by Orelabrutinib Sales

CompanyDeals

Porton Biologics Completes RMB 520M Series B to Expand Gene and Cell Therapy CDMO Platform

CompanyDrug

Nuance Pharma Gets NMPA Green Light for Ensifentrine COPD Trials in China

Company

Lundbeck’s Vyepti Fails to Accelerate China Launch via SUNLIGHT Trial

Company

Mindray Bio-Medical’s H1 2022 Revenues Jump 20.17% to RMB 15.3B

CompanyDeals

JJET Raises RMB 700M in Series A+ and B Rounds for Cardiac Electrophysiology Products

CompanyDrug

IASO Biotherapeutics’ BCMA CAR-T Therapy Approved for NMOSD in China

Company

Hengrui Medicine’s H1 2022 Revenues Drop 23% Amid Generic Price Cuts and COVID-19 Disruptions

CompanyDrug

Allist Pharmaceuticals Receives NMPA Approval for Furmonertinib in Exon 20 Insertion NSCLC